Migraine patients share real-world treatment hurdles in new thai study
NCT ID NCT07035197
First seen Apr 14, 2026 · Last updated Apr 30, 2026 · Updated 3 times
Summary
This study looked at what makes it easier or harder for migraine patients and healthcare workers in Thailand to use a new preventive treatment called eptinezumab. Thirty participants, including patients and providers, shared their experiences through interviews and questionnaires over six months. The goal is to improve access and care for migraine in middle-income countries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
King Chualongkorn Memorial Hospital, the Thai Red Cross Society
Bangkok, 10330, Thailand
Conditions
Explore the condition pages connected to this study.